Louise is an accomplished scientific leader with over 20 years’ experience in pre-clinical and clinical therapeutic research across various modalities and therapeutic areas. Formerly Vice President of Immunology Research at GlaxoSmithKline (GSK), she led the generation and advancement of a pipeline of assets from target identification through to clinical proof-of-concept studies. In her career, Louise has led research teams at Boehringer Ingelheim Pharmaceuticals and Millennium Pharmaceuticals (now Takeda), as well as represented GSK on the board of Sitryx.
Louise completed her PhD in Developmental Hematology at EMBL, Heidelberg, Germany and postdoctoral fellowship at Harvard University, Boston.
The Cell Reprogrammer – The Medicine Maker featuring Dr. Louise Modis